Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/08/2005US20050272163 Separating from excipient active hematinic species present in iron-saccharidic compositions, such as sodium ferric gluconate complex, ferric hydroxide-sucrose complex and ferric saccharate complex; analytical quantification by liquid chromatography and lasers of molecular characterisations; drugs
12/08/2005US20050272161 Fixed-dried red blood cells or blood platelets carrying an active agent which, upon reconstitution, adhere to thrombogenic surfaces, undergo shape change, form a hemostatic plug, and release their granular contents
12/08/2005US20050272133 A C9-deoxomeridamycin, used as a neuroregenerative agent
12/08/2005US20050272132 For therapy of a fungal infection
12/08/2005US20050272091 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection
12/08/2005US20050272083 EGFR mutations
12/08/2005US20050272055 Method of treating lethal shock induced by toxic agents and diagnosing exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes
12/08/2005US20050272054 detecting specific single nucleotide polymorphisms (SNPs) in the human genome, and their association with acute coronary events and/or variability in the responsiveness to statin treatment (including preventive treatment) between different individuals; assessing for risk of heart disease
12/08/2005US20050272051 Methods of preventing or treating recurrence of myocardial infarction
12/08/2005US20050272045 Anti-Hpr6 agents, to enhance the killing effect of anti-cancer agents in non-sarcoma tumor cells and to teat non-sarcoma tumors
12/08/2005US20050272036 Ketones
12/08/2005US20050271791 Methods for producing sterol esters of omega-3 fatty acids
12/08/2005US20050271758 Topical compositions containing Bacillus coagulans extracellular products and uses thereof
12/08/2005US20050271755 Phytomedicinal compositions for the control of lipid accumulation and metabolism in mammals
12/08/2005US20050271754 Composition for prevention or treatment of an alcohol hangover
12/08/2005US20050271749 Electrolyte purgative
12/08/2005US20050271748 Compositions for treating hyperemia
12/08/2005US20050271747 Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor
12/08/2005US20050271744 Comprising a peptide fraction which is preferably rich in di- and tripeptides in combination with an insulin sensitizer, preferably a natural or pharmaceutical insulin sensitizer; suitable as pharmaceutical or food or a food supplement; especially useful for Type 2 diabetes
12/08/2005US20050271726 Immune enhancing compositions and methods of use thereof
12/08/2005US20050271725 Adhesive gel composition for iontophoresis preparation and process for producing the same
12/08/2005US20050271724 Sugar coatings and methods therefor
12/08/2005US20050271723 Dosage forms for treatment of benign prostatic hyperplasia
12/08/2005US20050271721 Carvedilol-hydrophilic solutions
12/08/2005US20050271720 Pharmaceutical composition containing irbesartan
12/08/2005US20050271718 Sustained release propafenone hydrochloride capsules
12/08/2005US20050271717 Dry-granulated dosage forms of tablets or capsules; preparation by compressing the mixture, milling, grinding or sieving the compressed material; hypercholesterolemia, hyperlipidemia, osteoporosis, benign prostatic hyperplasia, and Alzheimer's disease
12/08/2005US20050271716 Preparation containing basic drug
12/08/2005US20050271715 Conjugate having a cleavable linkage for use in a liposome
12/08/2005US20050271714 a cationic lipid; and a taxane in a lipid bilayer of the taxane crystal free liposome
12/08/2005US20050271711 Therapeutic antimicrobial compositions and methods
12/08/2005US20050271707 Dry powder; administering through feeding tube
12/08/2005US20050271706 Longitudinal body with polymeric coating; triamcinolone acetonide; drug delivery to eye
12/08/2005US20050271705 Retinoid-containing sustained release intraocular drug delivery system and related methods
12/08/2005US20050271703 Controlled release bioactive agent delivery device
12/08/2005US20050271699 Biodegradable composition with prolonged release of the biological active compound and preparation thereof
12/08/2005US20050271691 Prepackaged aqueous pharmaceutical formulations
12/08/2005US20050271669 For therapy of proliferative disease
12/08/2005US20050271661 Synergistic mixture with glucocorticoid receptors antagonist
12/08/2005US20050271657 Intermittent treatment regime for organ failure
12/08/2005US20050271645 combination of lysozyme with an antibiotic: Ampicillin, Sulbactam, Cefotaxime, Ceftriaxone, Cefepime, Imipenem, Meropenem, Piperacillin, Tazobactam, Azithromycin, Clarithromycin, Erythromycin, Vancomycin, Clindamycin, Gatofloxicin, Levofloxacin, Moxifloxacin, Ciprofloxacin etc. to treat pneumonia
12/08/2005US20050271630 Method for treating cancer
12/08/2005US20050271618 Methods of reducing aggregation of IL-1ra
12/08/2005US20050271617 Biodegradable bio-absorbable material for clinical practice
12/08/2005US20050271616 Novel block polymers, compositions comprising them, and processes for treating kerating materials therewith
12/08/2005US20050271615 Self-immolative dendrimers releasing many active moieties upon a single activating event
12/08/2005US20050271613 Beta-1, 3-1, 6-D-glucan and its use
12/08/2005US20050271606 Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
12/08/2005US20050271603 Compositions comprising lactoferrin
12/08/2005US20050271600 Fiber supplement
12/08/2005US20050271597 Prostate hypertrophy treatment composition and method
12/08/2005US20050271596 Vasoactive kit and composition and uses thereof
12/08/2005US20050271590 Treatment of myopia
12/08/2005US20050271588 Liposome targeting of matrix metalloproteinase inhibitors
12/08/2005US20050271587 Exposing the cancer cell to a peptide has antiestrotrophic activity and is eight to twenty amino acids long; use of tamoxifen therapy in combination with the peptide therapy
12/08/2005US20050269722 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
12/08/2005US20050269546 Valve with a two-component seal
12/08/2005US20050269238 Dispenser for progestin used for acute and maintenance treatment of DUB
12/08/2005US20050268908 Medicament dispenser
12/08/2005DE60017281T2 Nomegestrolacetat und östrogen enthaltende Hormonzusammensetzung und ihre Verwendung Nomegestrol acetate and estrogen hormone-containing composition and its use
12/08/2005DE4213005B4 Verwendung von Aromatasehemmern zur Empfängnisverhütung bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus Use of aromatase inhibitors for contraception in female primates without affecting the menstrual cycle
12/08/2005DE3745196B4 1,2,4-Benzotriazine oxide derivs. - used for radio-sensitising hypoxic tumour cells and selectively killing hypoxic tumour cells
12/08/2005DE202004020671U1 Pravastatin Pravastatin
12/08/2005DE102004025324A1 Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung Liquid preparation for veterinary medicine, process for their preparation and their use
12/08/2005DE102004024452A1 Aerosolformulierung für die Inhalation von Betaagonisten An aerosol formulation for inhalation of beta agonists
12/08/2005DE102004024241A1 Water-soluble starch acetate useful in biomedical, pharmaceutical and food applications, especially as a blood plasma expander
12/08/2005DE102004024140A1 Konservierungsmittel für medizinische Vorrichtungen Preservatives for medical devices
12/08/2005DE102004023984A1 Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol Film-shaped, orally administrable pharmaceutical composition containing estriol
12/08/2005DE102004023930A1 Schnell lösliches Granulat von Bromhexin/Bromhexinhydrochlorid, Verfahren zu dessen Herstellung und dessen Verwendung Fast-dissolving granules of bromhexine / bromhexine hydrochloride, processes for its preparation and its use
12/08/2005DE102004023828A1 Lösung für die Peritonealdialyse Solution for peritoneal dialysis
12/08/2005DE102004023122A1 Kationische Farbstoffe und diese Verbindungen enthaltende Färbemittel für Keratinfasern Cationic dyes and colorants comprising these compounds for keratin fibers
12/08/2005DE102004023069A1 Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil New dosage forms of the PDE 5 inhibitor vardenafil
12/08/2005DE102004022928A1 Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung Powder containing Oligosacharidgemische novel and processes for their preparation
12/08/2005DE102004022253A1 Verwendung von Pirinixinsäure und deren Salzen zur Behandlung von chronisch entzündlichen Krankheiten Using Pirinixinsäure and salts thereof for the treatment of chronic inflammatory diseases
12/08/2005DE102004017662B3 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors
12/08/2005DE10021731B4 Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben Cyclipostins, processes for their preparation and pharmaceutical preparation thereof
12/08/2005CA2848881A1 Treatment of depressive disorders
12/08/2005CA2824612A1 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
12/08/2005CA2772033A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2772029A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2771951A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2771941A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2771940A1 Compositions and methods for bone formation and remodeling
12/08/2005CA2577415A1 Enhancement of antitubercular activity of extracts of salicornia brachiata
12/08/2005CA2569320A1 Drug for ameliorating male climacteric disorder
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568766A1 Crth2 receptor ligands for medicinal uses
12/08/2005CA2568742A1 Substituted thiazoleacetic as crth2 ligands
12/08/2005CA2568714A1 A biomolecule-containing formulation of increased stability
12/08/2005CA2568578A1 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof
12/08/2005CA2568542A1 Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
12/08/2005CA2568409A1 A chronic joint inflammation-modulating composition made of collagen-polyvinylpyrrolidone
12/08/2005CA2568134A1 Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
12/08/2005CA2568056A1 Tetraazabenzo[e]azulene derivatives and analogs thereof
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2568009A1 Use of ppar agonists to treat ruminants
12/08/2005CA2567969A1 Compositions comprising flavonoids and tocotrienols and methods thereof
12/08/2005CA2567963A1 Functional foods comprising flavonoids and tocotrienols and methods thereof
12/08/2005CA2567959A1 Pharmaceutical products for treating neoplastic disease and inflammation
1 ... 4442 4443 4444 4445 4446 4447 4448 4449 4450 4451 4452 4453 4454 4455 4456 4457 4458 4459 4460 4461 4462 ... 7860